Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 74359 · Class II · Oklahoma Blood Institute - Sylvan N Goldman Center
Key facts
| Event ID | 74359 |
|---|---|
| Recall numbers | B-0585-16 |
| Recalling firm | Oklahoma Blood Institute - Sylvan N Goldman Center |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Apheresis products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. |
| Initiation date | Apr 28, 2016 |
| Report date | Jun 22, 2016 |
| Termination date | Jun 14, 2016 |
| City | Oklahoma City |
| State | OK |
| Country | United States |
| FEI number | 1626009 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: